Onco-Vac Biopharma Private Limited - Company Profile

It is a research & development private limited company based in Delhi, Delhi, India, established in 2022.
2022 Delhi, Delhi, India Active
Last Updated:
Access Report
About Onco-Vac Biopharma Private Limited

Onco-Vac Biopharma Private Limited, a active private limited company, was established on 16 September 2022 in Delhi, Delhi, India. Engaging in science research within the research & development sector, it holds CIN: U73100DL2022PTC404697. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Raj Kumar Mallick (Director), Ashok Kumar Vaid (Director), Ram Vishwakarma Asrey (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-3/53 T/F, Janakpuri, Delhi, Delhi, 110058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100DL2022PTC404697

  • Registration Number

    404697

  • Incorporation Date

    16 September 2022

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Onco-Vac Biopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Onco-Vac Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Onco-Vac Biopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Raj Kumar Mallick Director 16 Sep 2022 Current
Ashok Kumar Vaid Director 16 Sep 2022 Current
Ram Vishwakarma Asrey Director 10 Feb 2023 Current
Anant Vishwakarma Director 14 Nov 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Onco-Vac Biopharma.

Enhance accessibility to Onco-Vac Biopharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Onco-Vac Biopharma revenue growth over time
Onco-Vac Biopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Onco-Vac Biopharma?

Unlock access to Onco-Vac Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Onco-Vac Biopharma?

Onco-Vac Biopharma has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Onco-Vac Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onco-Vac Biopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Onco-Vac Biopharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Onco-Vac Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Onco-Vac Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Ram Vishwakarma Asrey was appointed as a Director was appointed as a Director on 10 Feb 2023 & has been associated with this company since 3 years 8 days . was documented.

  • Director Appointment

    Progress on Anant Vishwakarma was appointed as a Director was appointed as a Director on 14 Nov 2022 & has been associated with this company since 3 years 3 months . was documented.

  • Director Appointment

    Progress on Raj Kumar Mallick was appointed as a Director was appointed as a Director on 16 Sep 2022 & has been associated with this company since 3 years 5 months . was documented.

  • Director Appointment

    The activity Ashok Kumar Vaid was appointed as a Director was appointed as a Director on 16 Sep 2022 & has been associated with this company since 3 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Onco-Vac Biopharma Private Limited?

The CIN of Onco-Vac Biopharma Private Limited is U73100DL2022PTC404697.

Where is Onco-Vac Biopharma Private Limited headquartered?

Onco-Vac Biopharma Private Limited is headquartered at B-3/53 T/F, Janakpuri, Delhi, Delhi, 110058.

When was Onco-Vac Biopharma Private Limited incorporated?

Onco-Vac Biopharma Private Limited was incorporated on 16 September 2022.

Who are the current directors of Onco-Vac Biopharma Private Limited?

The current directors of Onco-Vac Biopharma Private Limited are

What is the primary industry of Onco-Vac Biopharma Private Limited?

The primary industry of Onco-Vac Biopharma Private Limited is Research & Development.

Is Onco-Vac Biopharma Private Limited a listed company?

Onco-Vac Biopharma Private Limited is unlisted.

What is the capital structure of Onco-Vac Biopharma Private Limited?

The authorized capital of Onco-Vac Biopharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available